Cell-surface markers expressed by dendritic cells generated in vitro from CD34+ human intrathymic precursors
CD1a | +++ |
CD1c | + |
CD4 | ++ |
CD5 | − |
CD7 | +/− |
CD8 | − |
CD11b | ++ |
CD11c | ++ |
CD13 | +++ |
CD14 | +/− |
CD33 | ++ |
CD40 | ++ |
CD44 | ++ |
CD45RA | + |
CD45RO | ++ |
CD54 | +++ |
CD80 | + |
CD83 | ++ |
CD86 | + |
CD116 (GM-CSFR) | + |
CD123 (IL-3Rα) | +/− |
HLA-DR | +++ |
CD1a | +++ |
CD1c | + |
CD4 | ++ |
CD5 | − |
CD7 | +/− |
CD8 | − |
CD11b | ++ |
CD11c | ++ |
CD13 | +++ |
CD14 | +/− |
CD33 | ++ |
CD40 | ++ |
CD44 | ++ |
CD45RA | + |
CD45RO | ++ |
CD54 | +++ |
CD80 | + |
CD83 | ++ |
CD86 | + |
CD116 (GM-CSFR) | + |
CD123 (IL-3Rα) | +/− |
HLA-DR | +++ |
Flow cytometry analyses were performed by day 10 on in vitro–derived dendritic cells generated from CD34hiCD33lo human thymic progenitors in multicytokine-supported cultures.
GM-CSFR indicates granulocyte macrophage–colony-stimulating factor receptor; IL-3Rα, interleukin 3 receptor alpha.